NFE2L2 and liver cancer: Studies have shown that the inhibition of GSK-3β lowers the level of nuclear Nrf2 through nuclear export and degradation of Nrf2 in liver cancer cells and improves cell survival during the later phases of oxidative stress [52, 53].